The Global Point of Care Molecular Diagnostics Market size was estimated to be US$ 1.91 billion in 2019. The market is expected to grow at a CAGR of 13% through 2030. Point-of-care (POC) diagnostics offer fast pragmatic statistics for patient care at the moment and place of an appointment with the health care arrangement. POC Molecular testing empowers doctors to enhance the standard of care by blending quick analysis with therapy decisions in the first appointment by the patient instead of hours and days to have the test results. This would help recommend therapy on the first occasion without having to delay the last outcomes. Moreover, refining information in the understanding of molecular devices in the common plus uncommon diseases and the development of DNA sequencing and examination are some more factors that are anticipated to improve POC molecular diagnostics abilities. The Global Point of Care Molecular Diagnostics Market size was estimated to be US$ 2.1 billion in 2019, the growth rate is expected to be 11% thorugh 2030. Furthermore, the rising rate of contagious and breathing sicknesses, increasing elderly populace all over the world, escalating demand of home health care services accompanied by innovative products, growing funding from government authorities and private organizations, increasing emphasis on dispersed diagnosis are some of the main factors that are driving the market growth in the evaluation period
Read More@https://www.insightslice.com/point-of-care-molecular-diagnostics-market
